Skip to search formSkip to main contentSkip to account menu

Potassium bitartrate 900 MG / Sodium Bicarbonate 600 MG Rectal Suppository [Ceo-Two]

Known as: K+ bitartrate 900 MG / NaHCO3 600 MG Rectal Suppository [Ceo-Two], POTASSIUM BITARTRATE 927 mg in 3.7 g / SODIUM BICARBONATE 618 mg in 3.7 g RECTAL SUPPOSITORY [CEO-TWO], Ceo-Two (potassium bitartrate 0.9 GM / sodium bicarbonate 0.6 GM) Rectal Suppository 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Recent literature finds that a CEO's media visibility leads to improved career outcomes. However, the literature has been quiet… 
2011
2011
This Article identifies a cost to public investors of tying executive pay to the future value of a firm’s stock - even its long… 
2010
2010
We analyze the impact of incentive mechanisms embedded in executive remuneration contracts on the risk choices made by bank CEOs… 
2005
2005
A difference frequency generation scheme that is potentially applicable to self-stabilization of the carrier-envelope-offset… 
1999
1999
Etheno adducts are formed after exposure to a number of carcinogens, including vinyl chloride, as well as endogenously as a… 
1996
1996
The genetic toxicity profiles of vinyl chloride (VCl), vinyl bromide (VBr), ethyl carbamate (EC), vinyl carbamate (VC) and some… 
1986
1986
Published results and work from this laboratory permit the characterization of the possible promutagenic lesions induced by…